288 related articles for article (PubMed ID: 19220181)
1. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
2. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
Yew SQ; Chia YC; Theodorakis M
Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
5. External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.
Bannister CA; Poole CD; Jenkins-Jones S; Morgan CL; Elwyn G; Spasic I; Currie CJ
Diabetes Care; 2014 Feb; 37(2):537-45. PubMed ID: 24089541
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
McCallum RW; Burgess JR; Greenaway TM
Med J Aust; 2009 Jul; 191(1):47-8; author reply 48. PubMed ID: 19580543
[No Abstract] [Full Text] [Related]
7. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP; Patel A; Colagiuri S; Heller S; Hamet P; Marre M; Pan CY; Zoungas S; Grobbee DE; Neal B; Chalmers J; Woodward M;
Diabetologia; 2010 May; 53(5):821-31. PubMed ID: 20157695
[TBL] [Abstract][Full Text] [Related]
8. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
[TBL] [Abstract][Full Text] [Related]
9. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
[TBL] [Abstract][Full Text] [Related]
10. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
[TBL] [Abstract][Full Text] [Related]
11. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
Simmons RK; Coleman RL; Price HC; Holman RR; Khaw KT; Wareham NJ; Griffin SJ
Diabetes Care; 2009 Apr; 32(4):708-13. PubMed ID: 19114615
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.
Kim CJ; Kang HS; Schlenk EA; Chae SM
Diabetes Educ; 2015 Apr; 41(2):203-13. PubMed ID: 25699567
[TBL] [Abstract][Full Text] [Related]
13. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
[TBL] [Abstract][Full Text] [Related]
14. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study.
Lu SE; Beckles GL; Crosson JC; Bilik D; Karter AJ; Gerzoff RB; Lin Y; Ross SV; McEwen LN; Waitzfelder BE; Marrero D; Lasser N; Brown AF
BMC Endocr Disord; 2012 Jul; 12():12. PubMed ID: 22776317
[TBL] [Abstract][Full Text] [Related]
16. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
17. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
19. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.
Muntner P; Colantonio LD; Cushman M; Goff DC; Howard G; Howard VJ; Kissela B; Levitan EB; Lloyd-Jones DM; Safford MM
JAMA; 2014 Apr; 311(14):1406-15. PubMed ID: 24682252
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic surgery on 10-year cardiovascular disease risk in Chinese individuals with type 2 diabetes.
Ke Z; Li F; Zhou X; Sun F; Zhu Z; Tong W
Surg Obes Relat Dis; 2021 Mar; 17(3):498-507. PubMed ID: 33358863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
